Galaxy Biomedical Investment Co., Ltd. (000806-SZ) Stock Split, History Data
Working capital analysis
In terms of working capital, Galaxy Biomedical Investment Co., Ltd. maintains a healthy position.
The total current assets of the company are valued at $1462828859.
This represents a growth rate of 29.176% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $78008348, exhibiting a growth rate of -7.764% year-on-year.
The receivables, another significant portion of the current assets, are valued at $1177448659.
The year-on-year growth rate for receivables is 55.052%.
The inventory, which forms a critical part of the assets, is valued at $199623488.
This represents a healthy year-on-year growth of -28.833%
On the liabilities side, the company's current liabilities total $1043609631.
This reflects a growth rate of 30.283% over the previous year, indicating the company's financial obligations are well under control.
2022
2021
2020
2019
2018
2017
Cash and investments
78.01
84.58
110.00
100.44
50.75
265.88
Receavebles
1177.45
759.39
1146.19
696.07
1414.15
1208.32
Inventory
199.62
280.50
233.44
259.52
230.22
482.69
Other
4.69
7.97
5.55
8.76
20.96
156.37
Total Current Assets
1462.83
1132.43
1519.93
1064.78
1716.08
2113.27
Acc Payable
285.36
261.00
304.09
339.79
265.75
295.21
Short Term Debt
189.20
109.26
99.44
122.25
530.50
229.00
Other Current Liab
569.05
18.11
310.18
460.75
228.81
213.17
Current Liabilities
1043.61
801.03
1139.09
1215.59
1036.53
737.38
Capital Structure
When examining the capital structure of Galaxy Biomedical Investment Co., Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Galaxy Biomedical Investment Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.
